Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
172.65
+7.04 (4.25%)
Oct 30, 2026, 2:30 PM EDT - Market open
Gilead Sciences Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Gilead Sciences stock has a consensus rating of "Buy" and an average price target of $160.19. The average 1-year stock price forecast is 7.22% lower than the current stock price, while the lowest is $126 (-27.02%) and the highest is $185 (+7.15%).
Price Target: $160.19 (-7.22%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 16 | 16 | 16 | 16 | 16 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 7 | 7 | 7 | 6 | 5 | 5 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 31 | 29 | 29 | 29 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $170 → $190 | Buy | Reiterates | $170 → $190 | +10.05% | Oct 30, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $158 → $181 | Buy | Maintains | $158 → $181 | +4.84% | Oct 30, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $177 → $200 | Buy | Maintains | $177 → $200 | +15.84% | Oct 30, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $163 → $183 | Buy | Reiterates | $163 → $183 | +5.99% | Oct 30, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $160 → $175 | Buy | Maintains | $160 → $175 | +1.36% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
30.76B
from 29.44B
Increased by 4.49%
Revenue Next Year
32.89B
from 30.76B
Increased by 6.92%
EPS This Year
-0.45
from 8.15
EPS Next Year
9.91
from -0.45
EPS and Forward PE are based on non-GAAP adjusted numbers.